knowledge logo

BEI Resources Knowledge Base


Search Our Knowledge Base

The Knowledge Base is an informational database assembled by our Support Specialists and Scientific Staff which provides additional knowledge about the BEI Resources program and reagents through questions and answers. In order to use the Knowledge Base, enter a keyword or phrase that best describes the information of interest. More >>
   

Showing 1 to 5 of 10 Results12
How are viruses propagated at BEI Resources?

Viruses are grown in the same host and growth conditions as the original ones deposited by scientists in order to maintain virus population characteristics. If adaptation to another host is required, this is accompanied by creation of a new catalog number for the resulting new product.

Author: BEI Resources
0 Comments
Rating:
Updated on: 5/5/2026 1:16:38 PM
How is viral nucleic acid product tested for residual viable virus?

Every lot of isolated nucleic acid produced is tested for the presence of any residual viable source virus by incubating 10% of each lot on a permissive host.

Author: BEI Resources
0 Comments
Rating:
Updated on: 5/5/2026 10:52:35 AM
How do you adapt an egg grown Influenza virus to cell culture?

When adapting influenza virus from one propagation host to another, it is important to passage the virus at least three times in the new host to allow for adequate adaptation. Each passage should be evaluated for virus growth, and it may also be necessary to check the titer of each passage to ensure that the virus is not being lost during adaptation.Additionally, it is recommended that WGS be performed to characterize any tissue‑culture&ndash adaptive mutations that may have occurred during passage, in order to make an informed assessment of their impact on the intended end use. When changing the propagation host, it is also important to consider whether adjustments are needed to the viral growth medium, temperature, and&mdash if applicable&mdash cell confluency, based on the properties of the new host system. For propagating influenza virus in tissue culture, the viral growth medium should not contain fetal bovine serum (FBS), as serum will neutralize the activity of TPCK‑treated t ...

Author: BEI Resources
0 Comments
Rating:
Updated on: 5/5/2026 10:56:31 AM
The medium listed on the virus product information sheet does not include any antibiotics. Should I add antibiotics to my medium?
BEI Resources does not use any antibiotics in the virus medium as antibiotics can influence the growth of the virus. Antibiotics may be used initially while curing a contaminated virus isolate. However, once the viral stock is cured, the passage of virus grown for distribution through BEI Resources is antibiotic-free.
Author: BEI Resources
0 Comments
Rating:
Updated on: 4/15/2026 3:29:09 PM
What is the importance of testing TPCK-treated trypsin lots from the same vendor when using it as a supplement in influenza virus growth in MDCK cells? How should it be tested?
TPCK-treated trypsin is available from several manufacturers. It is available in varying concentrations from different manufacturers, and some manufacturers offer the product based on specific activity, not concentration. Additionally, concentration will depend on purity. Therefore, it is important to determine the appropriate concentration of each lot of TPCK-trypsin used in the lab. To determine the appropriate concentration, the host cells should first be at 100% confluency before TPCK-treated trypsin is added. Then various concentrations should be tested on the 100% confluent host cell monolayer to determine the highest concentration that can be added to the cells without causing cytotoxicity to the host cell monolayer for the duration of the incubation period needed for growth of the virus. This testing should be conducted for each cell line that may be used with TPCK-treated trypsin to grow influenza virus, and must be repeated with each new lot of TPCK-treated trypsin.
Author: BEI Resources
0 Comments
Rating:
Updated on: 5/5/2026 1:10:43 PM
Showing 1 to 5 of 10 Results12

Showing 1 to 5 of 9 Results12
SARS Virus Now Available for Researchers
We have available for the first time in the BEI Resources catalog, two SARS Coronaviruses (SARS-CoV) derived from the Urbani strain. NR-18925 is produced from a recombinant infectious clone, icSARS-CoV. NR-15418 is the mouse-adapted strain, Urbani v2163, developed by Dr. Barnard as a lethal model fo ...
Author: BEI Resources
0 Comments
Rating:
Updated on: 12/4/2018 2:36:38 PM
Sand Flies, Reduviids and Ticks are Here!
BEI Resources announces the addition of Sand Flies, Reduviids and Ticks for the research community. Catalog Number Vector Pathogen Competence   NR-43999 Phlebotomus papatasi, PPNS, Larval Leishmania major and Sand Fly Fever phleboviruses.   NR-44000 Phlebotomus papata ...
Author: BEI Resources
0 Comments
Rating:
Updated on: 12/4/2018 2:32:27 PM
Development of let digital PCR for the detection of Babesia microti and Babesia duncani
Development of let digital PCR for the detection of Babesia microti and Babesia duncani Babesia spp. are obligate protozoan parasites of red blood cells. Transmission to humans occurs through bites from infected ticks or blood transfusion. Infections with B. microti account for the majority of the ...
Author: BEI Resources
0 Comments
Rating:
Updated on: 12/9/2014 10:58:36 AM
Mycobacterium tuberculosis Production Manuals & SOP's from Dr. Karen Dobos
Please use this link  to find a comprehensive list of  protocols and SOPs for Mycobacterium tuberculosis including: Large Scale Growth Subcellular Fractions Preparation and Fractionation of Cell Wall Proper Lipoarabinomannan (LAM) and Lipomannan (LM) Antibodies Microarrays Media Native Ma ...
Author: BEI Resources
0 Comments
Rating:
Updated on: 11/20/2014 11:18:21 AM
BEI Resources Fungi Catalog is Growing!
  BEI Resources is working to expand the fungal catalog so that researchers have a broader range of organisms and reagents for their work.  BEI Resources currently has eight genus and species represented with several more currently going through the production pipeline.  BEI Resources i ...
Author: BEI Resources
0 Comments
Rating:
Updated on: 8/29/2014 9:49:43 AM
Showing 1 to 5 of 9 Results12
The following is a list of published abstracts and papers where the work was either facilitated, or directly supported, by the BEI Resources Program.


Showing 1 to 5 of 11494 Results12345678910...>>
Cheng, W.T., et al., Infants under 24 months with severe malaria have a serological profile of active infection with Epstein Barr Virus The Journal of Infectious Diseases, 2026.
Author: BEI Resources
Updated on: 10/16/2026 11:03:13 AM
Chen, Z., et al., The 5&prime -Isobutyryl Ester Prodrug of 4&prime -Thiouridine Inhibits SARS-CoV-2 Replication in Culture and in a Syrian Hamster Infection Model. ACS Omega, 2026.
Author: BEI Resources
Updated on: 10/16/2026 11:02:37 AM
Chaudhary, P., et al., Standardized Protocol for Raising Rabbit Anti-MTB Polyclonal Antibodies using Mycobacterium tuberculosis H37Rv Soluble Extract Antigen. Indian Journal of Tuberculosis, 2026.
Author: BEI Resources
Updated on: 10/16/2026 11:02:22 AM
Chan, W.C., Targeting Endothelial Pathological Calcium Signaling Accelerates Resolution of SARS-CoV-2-Induced ARDS. 2026, University of Illinois at Chicago.
Author: BEI Resources
Updated on: 10/16/2026 11:01:51 AM
Chakraborty, B., S.M. McGee, and S. Kumar, An MKT1 domain protein is dispensable for erythrocytic stages of plasmodium falciparum. Frontiers in Microbiology, 2026. Volume 17 - 2026.
Author: BEI Resources
Updated on: 10/16/2026 11:01:35 AM
Showing 1 to 5 of 11494 Results12345678910...>>
The following is a list of published abstracts and papers where the work was either facilitated, or directly supported, by the NIH HIV Reagent Program.



Showing 1 to 5 of 1315 Results12345678910...>>
Author: HIV
Updated on: 3/28/2024 8:38:45 PM

2009 - 2011 Journal Citations

Author: HIV
Updated on: 3/28/2024 8:38:45 PM

2006 - 2008 Journal Citations

Author: HIV
Updated on: 3/28/2024 8:38:45 PM

2003 - 2005 Journal Citations

Author: HIV
Updated on: 3/28/2024 8:38:45 PM

2000 - 2002 Journal Citations

Author: HIV
Updated on: 3/28/2024 8:38:45 PM
Showing 1 to 5 of 1315 Results12345678910...>>


Sorry, there are no questions found for the search criteria at this time.